HistoIndex Partners Houston Research Institute to Expand AI-Driven Diagnostics for MASH Care
HistoIndex has partnered with Houston Research Institute to deploy AI-powered digital pathology and fibrosis assessment tools across HRI centres, enhancing diagnostic precision and clinical decision-making for MASH patients.
Gastroenterology | 21/01/2026 | By News Bureau | 166
Lilly Completes Acquisition of Morphic
Morphic is a biopharmaceutical company developing oral integrin therapies for the treatment of serious chronic diseases, including a selective oral small molecule inhibitor of α4β7 integrin (known as MORF-057) for inflammatory bowel disease (IBD).
Gastroenterology | 17/08/2024 | By Aishwarya | 554
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy